Funds

Since 1997, NeoMed Management has raised four investment funds with total commitments of approximately €170 million. 

NeoMed VI, III and II are closed-end venture capital funds whilst NeoMed I (The NeoMed Fund) was an open-ended public equity fund. Each venture capital fund has been focused on investing in emerging companies with innovative medical products in Europe and North America.

NeoMed IV (NeoMed Innovation IV, LP), established in 2005. Total committed capital: €104 million. With the exception of follow-on investments, NeoMed IV is fully invested.

NeoMed III (NeoMed Innovation III, LP), established in 2001. Total committed capital: €32 million. With the exception of follow-on investments, NeoMed III is fully invested.

NeoMed II (NeoMed Innovation ASA with syndicates), established in 1998. Total committed capital: €14 million. NeoMed II was terminated in 2010.

NeoMed I (The NeoMed Fund), established in 1997. NeoMed I had paid-in capital of about €17 million. The fund was an evergreen fund listed on the Irish Stock Exchange. From 1997 to 2004 NeoMed I invested in about 55 private and public companies, predominantly in the US. NeoMed I was terminated in 2006.